Press Release

Sep, 22 2020

Allergan, INMODE, HIRONIC CO., LTD are Dominating the Global Submental Fat Treatment Market in 2019

Global Submental Fat Treatment Market is expected to grow with the CAGR of 13.2% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access full Report @

Global submental fat treatment market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in global submental fat treatment market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In March 2017, Hironic Co. Ltd. Has launched Double gold which gives easier and faster treatment for fat reduction. It has reduced the time for fat treatment. This product launch is going to increase patient’s attention towards company and going to enhance company’s profile in the market.

Allergan is the dominating player in global submental fat treatment market. The other key players existing in the market includes CANDELA CORPORATION, Cynosure LLC, Lumenis, INMODE, Cutera, Laser Lipo Ltd, Solta Medical, ERCHONIA CORPORATION, ALASTIN Skincare, ThermiGen, LLC., BTL Group of Companies, Alma Lasers (A Subsidiary of Sisram Medical Ltd), HIRONIC CO., LTD., ENDYMED MEDICAL.

Submental Fat Treatment MarketAllergan

Allergan headquartered in Dublin, Ireland and was founded in 2013. The company mainly focuses on commercializing and manufacturing of branded pharmaceutical, devices, surgical and regenerative medicine products and biologic for patients around the world.  The company has multiple business segments including US specialized therapeutics, US general medicine, international and corporate. In this US General medicine is the market focussed segment. The company has wide product portfolio such as central nervous treatment, eye care, gastroenterology, medical aesthetics, and patient assistance programs, in which medical aesthetics is the market focussed category. The company has wide presence across Europe, Asia-Pacific, Middle East & Africa, and Americas. The company also has various subsidiary companies such as Allergan Productos Farmaceuticos S.A. (Argentina), Allergan Australia Pty Limited (Australia), Allergan Holdings B Ltd(Belgium), Allergan Inc.(Brazil), Allergan Holdings France SAS (France)  among others.

  • In October 2016, Allergan received marketing authorization for BELKYRA by Swedish Medical Products Agency ( MPA) for treatment of fullness associated with submental fat. Through this approval, the company is penetrating into different countries and thus boosting the market growth.


INMODE headquartered in Israel and was founded in 2008. The company is engaged in developing, manufacturing and marketing of devices harnessing novel radiofrequency (RF ) based devices that strives to enable new emerging surgical procedures as well as to improve existing treatments. The company has wide product portfolio including treatments and workstations, in which workstations is the market focused category.The company has wide presence Europe, Middle East , South Africa, Asia-Pacific and South America. The company also has various subsidiary companies such as Invasix Iberia S.L.(Spain), Guangzhou InMode Medical Tecgnology Ltd.(China), InMode Asia Limited (Hongkong), InMode private limited( India) among others.


HIRONIC CO., LTD headquartered in Gyeonggi, Korea and was founded in 2008. The company is engaged in the manufacture, research and development, and distribution of medical equipment for skin care. The company is engaged in providing wide range of product categories such as cryotherapy system, laser, RF, cryofat reduction, fue hair transplant, IPL, plasma, HIFU in which HIFU is the market focused product category. The company is present in East Asia (Korea).

In March, 2017 Hironic Co. Ltd. Has announced the launch of Double Gold which provides easier and faster treatment for fat reduction. This product launch is going to increase company’s popularity and hence will aid on to generate more revenue.

Client Testimonials